Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
This service provides medical evaluation and ongoing clinical care for weight management
Mounjaro (tirzepatide) is a prescription medication licensed by the MHRA for the treatment of type 2 diabetes mellitus and for weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity
Semaglutide may commonly causes gastrointestinal side effects such as nausea, vomiting, diarrhea, and constipation
*In a 68-week clinical study of branded Semaglutide 2.4 mg with lifestyle intervention, mean body weight change was 14.9%
Aravamudhan says people taking Zepbound and having severe GI distress, like frequent vomiting or diarrhea, are at risk of electrolyte loss or imbalance, and headaches are a common symptom
US$ 29.74
US$ 25.85
US$ 28.83
US$ 24.00
US$ 21.51
US$ 26.26
US$ 22.76
US$ 24.28
